Netupitant N-oxide D6
| Product Name | Netupitant N-oxide D6 |
|---|---|
| Alternate Names | Netupitant Stable Isotopes, Stable Isotopes of Netupitant |
| CAT No. | CS-O-06807 |
| CAS No. | 2070015-12-0 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 600.63 g/mol |
| Mol. For. | C₃₀H₂₆D₆F₆N₄O₂ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Netupitant |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | CN(C1=CN=C(N(CC2)CC[N]2(C)=O)C=C1C(C=CC=C3)=C3C)C(C(C([2H])([2H])[2H])(C4=CC(C(F)(F)F)=CC(C(F)(F)F)=C4)C([2H])([2H])[2H])=O |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Netupitant N-oxide D6 is a deuterated form of Netupitant N-oxide, which is an antiemetic drug used to prevent nausea and vomiting caused by chemotherapy. Netupitant N-oxide D6 is a potent antagonist of the neurokinin-1 (NK1) receptor, which is involved in the regulation of vomiting and other physiological processes.
The chemical formula of Netupitant N-oxide D6 is C30H34D6N4O3, and its molecular weight is 508.67 g/mol. It is a white to off-white powder that is soluble in dimethyl sulfoxide (DMSO) and methanol.
Netupitant N-oxide D6 is typically administered as a single oral dose in combination with another antiemetic drug, palonosetron, to prevent acute and delayed nausea and vomiting associated with chemotherapy. It is usually given 30 minutes before chemotherapy treatment.
The safety and efficacy of Netupitant N-oxide D6 have been evaluated in several clinical trials. It has been shown to be effective in preventing chemotherapy-induced nausea and vomiting, with a favorable safety profile. Adverse effects are generally mild and include headache, constipation, and fatigue.
In conclusion, Netupitant N-oxide D6 is a valuable drug in the management of chemotherapy-induced nausea and vomiting. Its potent antiemetic effects and favorable safety profile make it a popular choice among healthcare providers.
Get an Instant Quote
Related Compounds
Netupitant D6 | Monohydroxy Netupitant D6 | Netupitant D8 | N-desmethyl netupitant D6 |